Study design and endpoints in graft-versus-host disease
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 21 (2) , 357-372
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved IssuesTransplantation and Cellular Therapy, 2008
- Graft-versus-host diseaseNature Reviews Immunology, 2007
- Immunobiology of Allogeneic Hematopoietic Stem Cell TransplantationAnnual Review of Immunology, 2007
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- Toward Biomarkers for Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. Biomarker Working Group ReportTransplantation and Cellular Therapy, 2006
- Pathophysiology of Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group ReportTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†Hepatology, 2005
- Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantationTransplantation and Cellular Therapy, 2004